- Home
- RGC vs DOMH Comparison
RGC vs DOMH Comparison
Compare RGC & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGC
- DOMH
- Stock Information
- Founded
- RGC 2014
- DOMH 1967
- Country
- RGC Hong Kong
- DOMH United States
- Employees
- RGC N/A
- DOMH N/A
- Industry
- RGC Medicinal Chemicals and Botanical Products
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- RGC Health Care
- DOMH Health Care
- Exchange
- RGC Nasdaq
- DOMH Nasdaq
- Market Cap
- RGC 377.5M
- DOMH 68.4M
- IPO Year
- RGC 2021
- DOMH N/A
- Fundamental
- Price
- RGC $212.00
- DOMH $5.32
- Analyst Decision
- RGC
- DOMH
- Analyst Count
- RGC 0
- DOMH 0
- Target Price
- RGC N/A
- DOMH N/A
- AVG Volume (30 Days)
- RGC 122.6K
- DOMH 194.7K
- Earning Date
- RGC 06-20-2025
- DOMH 05-20-2025
- Dividend Yield
- RGC N/A
- DOMH 6.01%
- EPS Growth
- RGC N/A
- DOMH N/A
- EPS
- RGC N/A
- DOMH N/A
- Revenue
- RGC N/A
- DOMH $18,146,000.00
- Revenue This Year
- RGC N/A
- DOMH N/A
- Revenue Next Year
- RGC N/A
- DOMH N/A
- P/E Ratio
- RGC N/A
- DOMH N/A
- Revenue Growth
- RGC N/A
- DOMH 789.95
- 52 Week Low
- RGC $3.03
- DOMH $0.83
- 52 Week High
- RGC $268.73
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- RGC 88.39
- DOMH 57.23
- Support Level
- RGC $27.70
- DOMH $4.40
- Resistance Level
- RGC $250.00
- DOMH $5.72
- Average True Range (ATR)
- RGC 29.96
- DOMH 0.43
- MACD
- RGC 18.26
- DOMH 0.15
- Stochastic Oscillator
- RGC 76.56
- DOMH 79.49
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.